HC Wainwright & Co. Maintains Buy on Prothena Corp, Lowers Price Target to $84
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Andrew Fein maintains a Buy rating on Prothena Corp (NASDAQ:PRTA) but lowers the price target from $90 to $84.

May 09, 2024 | 5:57 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Prothena Corp's Buy rating is maintained by HC Wainwright & Co., but the price target is reduced from $90 to $84.
The maintenance of a Buy rating indicates a positive outlook on Prothena Corp by HC Wainwright & Co., suggesting confidence in the company's fundamentals or future prospects. However, the reduction in the price target from $90 to $84, while still indicating an upside potential, suggests a recalibration of expectations possibly due to market conditions, recent company performance, or other factors not specified in the article. This mixed signal could lead to short-term uncertainty among investors, potentially stabilizing the stock price as the market absorbs the new target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100